Tarsus Pharmaceuticals Inc (NASDAQ: TARS) is -16.07% lower on its value in year-to-date trading and has touched a low of $20.08 and a high of $57.28 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TARS stock was last observed hovering at around $47.10 in the last trading session, with the day’s loss setting it -0.63%.
Currently trading at $46.47, the stock is 0.59% and -6.17% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.09 million and changing -1.34% at the moment leaves the stock 19.03% off its SMA200. TARS registered 52.36% gain for a year compared to 6-month gain of 47.81%. The firm has a 50-day simple moving average (SMA 50) of $49.5276 and a 200-day simple moving average (SMA200) of $39.03895.
The stock witnessed a -9.27% loss in the last 1 month and extending the period to 3 months gives it a -8.27%, and is 6.66% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.98% over the week and 5.99% over the month.
Tarsus Pharmaceuticals Inc (TARS) has around 323 employees, a market worth around $1.78B and $182.95M in sales. Fwd P/E is 42.19. Profit margin for the company is -63.16%. Distance from 52-week low is 131.40% and -18.87% from its 52-week high. The company has generated returns on investments over the last 12 months (-38.99%).
The EPS is expected to grow by 42.49% this year
263.0 institutions hold shares in Tarsus Pharmaceuticals Inc (TARS), with institutional investors hold 123.26% of the company’s shares. The shares outstanding are 38.35M, and float is at 33.12M with Short Float at 22.17%. Institutions hold 112.54% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 3.27 million shares valued at $88.79 million. The investor’s holdings represent 9.254 of the TARS Shares outstanding. As of 2024-06-30, the second largest holder is RTW INVESTMENTS, LP with 3.41 million shares valued at $92.75 million to account for 9.0222 of the shares outstanding. The other top investors are PARADIGM BIOCAPITAL ADVISORS LP which holds 2.44 million shares representing 6.4389 and valued at over $66.19 million, while TANG CAPITAL MANAGEMENT LLC holds 5.9614 of the shares totaling 2.25 million with a market value of $61.29 million.
Tarsus Pharmaceuticals Inc (TARS) Insider Activity
The most recent transaction is an insider sale by LINK WILLIAM J PHD, the company’s Director. SEC filings show that LINK WILLIAM J PHD sold 35,000 shares of the company’s common stock on Aug 12 ’24 at a price of $26.08 per share for a total of $0.91 million. Following the sale, the insider now owns 0.0 shares.
Still, SEC filings show that on Jun 18 ’24, Farrow Jeffrey S disposed off 10,445 shares at an average price of $27.47 for $0.29 million. The insider now directly holds 18,136 shares of Tarsus Pharmaceuticals Inc (TARS).
